KAZ Minerals (LON:KAZ) Price Target Lowered to GBX 575 at JPMorgan Chase & Co.

Share on StockTwits

KAZ Minerals (LON:KAZ) had its price target cut by JPMorgan Chase & Co. from GBX 590 ($7.71) to GBX 575 ($7.51) in a research report released on Thursday, Digital Look reports. They currently have a neutral rating on the copper miner’s stock.

Several other equities research analysts have also recently commented on KAZ. Deutsche Bank cut their price target on KAZ Minerals from GBX 680 ($8.89) to GBX 560 ($7.32) and set a hold rating for the company in a research note on Wednesday, September 4th. Liberum Capital restated a hold rating on shares of KAZ Minerals in a research note on Tuesday, July 16th. Royal Bank of Canada upped their price target on KAZ Minerals from GBX 620 ($8.10) to GBX 630 ($8.23) and gave the stock a sector performer rating in a research note on Friday, June 28th. UBS Group restated a buy rating on shares of KAZ Minerals in a research note on Friday, August 16th. Finally, HSBC upgraded KAZ Minerals to a buy rating and cut their price target for the stock from GBX 700 ($9.15) to GBX 690 ($9.02) in a research note on Tuesday, May 28th. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of GBX 700.83 ($9.16).

Shares of LON KAZ opened at GBX 459.80 ($6.01) on Thursday. The company has a current ratio of 1.57, a quick ratio of 0.89 and a debt-to-equity ratio of 185.76. KAZ Minerals has a twelve month low of GBX 375.80 ($4.91) and a twelve month high of GBX 744.80 ($9.73). The stock has a 50 day moving average of GBX 477.55 and a two-hundred day moving average of GBX 577.50. The stock has a market cap of $2.17 billion and a P/E ratio of 4.65.

The business also recently declared a dividend, which will be paid on Friday, October 25th. Stockholders of record on Thursday, October 3rd will be paid a dividend of GBX 3.30 ($0.04) per share. This represents a dividend yield of 0.79%. The ex-dividend date is Thursday, October 3rd. KAZ Minerals’s dividend payout ratio (DPR) is presently 0.07%.

In other KAZ Minerals news, insider Charles Watson acquired 3,246 shares of the business’s stock in a transaction on Thursday, August 15th. The stock was purchased at an average price of GBX 452 ($5.91) per share, for a total transaction of £14,671.92 ($19,171.46). Also, insider Andrew Southam sold 147,608 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of GBX 398 ($5.20), for a total value of £587,479.84 ($767,646.47).

KAZ Minerals Company Profile

KAZ Minerals PLC, together with its subsidiaries, engages in mining and processing copper and other metals primarily in Kazakhstan and Kyrgyzstan. It operates through Bozshakol, Aktogay, and East Region and Bozymchak segments. The company operates the Bozshakol open pit mine in the Pavlodar region of Kazakhstan; Aktogay open pit mine located in the east of Kazakhstan; three underground mines and concentrators located in the eastern region of Kazakhstan; and the Bozymchak copper-gold open pit mine located in western Kyrgyzstan.

Read More: Lock-Up Period Expiration

Analyst Recommendations for KAZ Minerals (LON:KAZ)

Receive News & Ratings for KAZ Minerals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KAZ Minerals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Investment Analysts’ Price Target Changes for October, 14th
Investment Analysts’ Price Target Changes for October, 14th
Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.